(Press-News.org) Researchers at the University of California, San Diego School of Medicine, with colleagues at the University of Rochester Medical Center, have identified a new mechanism that appears to suppress tumor growth, opening the possibility of developing a new class of anti-cancer drugs.
Writing in this week's online Early Edition of the Proceedings of the National Academy of Sciences (PNAS), Willis X. Li, PhD, a professor in the Department of Medicine at UC San Diego, reports that a particular form of a signaling protein called STAT5A stabilizes the formation of heterochromatin (a form of chromosomal DNA), which in turn suppresses the ability of cancer cells to issue instructions to multiply and grow.
Specifically, Li and colleagues found that the unphosphorylated form of STAT promotes and stabilizes heterochromatin, which keeps DNA tightly packaged and inaccessible to transcription factors. "Therefore, genes 'buried' in heterochromatin are not expressed," explained Li.
Phosphorylation is a fundamental cellular function in which a phosphate group is added to a protein or molecule, causing it to turn it on or off or to alter its function. An unphosphorylated STAT lacks this phosphate group.
Li said that in previous studies with fruit flies, the unphosphorylated form of STAT caused chromatin to condense into heterochromatin, while the phosphorylated version prompted dispersal and loss of heterochromatin, furthering gene expression.
"Unphosphorylated STAT promotes and stabilizes heterochromatin formation, which in turn suppresses gene transcription," said Li. "When we expressed either HP1 (the central component of heterochromatin) or unphosphorylated STAT5A in human cancer cells, many genes important for cancer growth are suppressed. These cancer cells do not grow as fast or big as their control parental cancer cells in mouse xenograft models."
Most of the known tumor suppressors, such as p53 or Rb, function by inhibiting cell cycle progression or by spurring cell death, or apoptosis. Li said their findings reveal a potential new way to inhibit cancer gene expression, and may represent a new class of tumor suppressors.
"We are in the process of identifying small molecule drugs that may promote heterochromatin formation without stopping cell division or causing cell death," he said. "These drugs, if found, may be effective in treating cancers with fewer side effects."
###
Co-authors are Xiaoyu Hu, Amy Tsurumi and Hartmut Land, Department of Biomedical Genetics, University of Rochester Medical Center; Pranabananda Dutta, Jinghong Li and Jingtong Wang, Department of Medicine, UCSD.
Funding for this research came, in part, from the National Institutes of Health grants R01CA131326 and RO1CA138249 and a Leukemia & Lymphoma Society Research Scholar grant.
END
Researchers at Karolinska Institutet in Sweden have found a promising strategy for defeating neuroblastoma – a malignant form of cancer in children – that focuses on the so-called MYCN protein. A specific chemical molecule helps to break down MYCN, which either kills the cancer cell or makes it mature into a harmless neuron. The discovery, which is published in the scientific journal PNAS, raises hopes for new and more effective treatments in the future.
Neuroblastoma is the third most common form of cancer in children. It usually develops before the age of two and affects ...
States that choose not to expand Medicaid under federal health care reform will leave millions of their residents without health insurance and increase spending, at least in the short term, on the cost of treating uninsured residents, according to a new RAND Corporation study.
If 14 states decide not to expand Medicaid under the Affordable Care Act as intended by their governors, those state governments collectively will spend $1 billion more on uncompensated care in 2016 than they would if Medicaid is expanded.
In addition, those 14 state governments would forego ...
Early-life risk factors -- most of which could be changed -- appear to explain the recognized racial and ethnic disparities in the incidence of childhood overweight and obesity. In a report being published online in JAMA Pediatrics, a team of researchers report a prospective study finding that increased prevalence of obesity and overweight among black and Hispanic 7-year-olds could largely be explained by risk factors such as rapid infant weight gain, early introduction of solid foods and a lack of exclusive breast feeding.
"We know that, already by the age of 2, black ...
PHILADELPHIA, PA June 2013—France is renowned the world over as a leader in the crafts of viticulture and winemaking—but the beginnings of French viniculture have been largely unknown, until now.
Imported ancient Etruscan amphoras and a limestone press platform, discovered at the ancient port site of Lattara in southern France, have provided the earliest known biomolecular archaeological evidence of grape wine and winemaking—and point to the beginnings of a Celtic or Gallic vinicultural industry in France circa 500-400 BCE. Details of the discovery are published as "The ...
To comply with a statewide "fair pricing" law, hospitals throughout California have significantly lowered prices to uninsured patients, with nearly all even going beyond the state mandate and offering free care to those below the poverty line.
The surprising success of the legislation represents the beginnings of a safety net not in place for other states.
Some 6.8 million people in California lack health insurance, often relying on hospital emergency departments for healthcare. Based on hospital billing plans, those visits can rack up huge bills that the uninsured ...
SAN FRANCISCO (June 3, 2013) — The old saying "You are what you eat" takes on new significance in the most comprehensive analysis to date of early human teeth from Africa. Prior to about 3.5 million years ago, early humans dined almost exclusively on leaves and fruits from trees, shrubs, and herbs—similar to modern-day gorillas and chimpanzees. However, about 3.5 million years ago, early human species like Australopithecus afarensis and Kenyanthropus platyops began to also nosh on grasses, sedges, and succulents—or on animals that ate those plants. Evidence of this ...
Diseases such as tuberculosis, anthrax, and shigellosis -- a severe food-borne illness -- eventually could be treated with an entirely new and more-effective kind of antibiotic, thanks to a team of scientists led by Kenneth Keiler, an associate professor of biochemistry and molecular biology at Penn State University. In a research paper that will be published in the journal Proceedings of the National Academy of Sciences during the week beginning 3 June 2013, the team describes 46 previously untested molecules that target and disrupt an important step in the process of ...
A new look at the diets of ancient African hominids shows a "game changer" occurred about 3.5 million years ago when some members added grasses or sedges to their menus, according to a new study led by the University of Colorado Boulder.
High-tech tests on tooth enamel by researchers indicate that prior to about 4 million years ago, Africa's hominids were eating essentially chimpanzee style, likely dining on fruits and some leaves, said CU-Boulder anthropology Professor Matt Sponheimer, lead study author. Despite the fact that grasses and sedges were readily available ...
GALVESTON, Texas — Prescriptions for testosterone therapy have increased significantly during the last 10 years, according to a study in the current issue of JAMA Internal Medicine conducted by researchers at the University of Texas Medical Branch.
About 50 percent of the men in the study who had received testosterone therapy had been diagnosed as having hypogonadism, a condition where a man is unable to produce the normal levels of testosterone.
But the study also found that, among new users of a prescription androgen product, about 25 percent did not have their testosterone ...
Using cholesterol-lowering statins may be associated with musculoskeletal conditions, arthropathies (joint diseases) and injuries, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.
While statins effectively lower cardiovascular illnesses and death, the full spectrum of statin musculoskeletal adverse events (AEs) is unknown. Statin-associated musculoskeletal AEs include a wide variety of clinical presentations, including muscle weakness, muscle cramps and tendinous (tendon) diseases, the authors write in the study background.
Ishak ...
